The Enterprise Value as of December 2025 (TTM) for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) is 1.20B

According to Taiwan Advance Bio-Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.20B. This represents a change of -23.45% compared to the average of 1.56B of the last 4 quarters.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Historical Enterprise Value (quarterly & annually)

How has 4186.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Taiwan Advance Bio-Pharmaceutical Inc. over the last ten years is 1.70B. The current 1.20B Enterprise Value has changed 6.94% with respect to the historical average. Over the past ten years (40 quarters), 4186.TWO's Enterprise Value was at its highest in in the December 2020 quarter at 2.09B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Taiwan Advance Bio-Pharmaceutical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Average Enterprise Value

How has 4186.TWO Enterprise Value performed in the past?

The current Enterprise Value of Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Enterprise Value vs. Peers

How is 4186.TWO’s Enterprise Value compared to its peers?

Taiwan Advance Bio-Pharmaceutical Inc.’s Enterprise Value is greater than LabTurbo Biotech Corporation (711.50M), greater than Bio Preventive Medicine Corp. (944.05M), less than Lukas Biomedical Inc. (1.42B), less than NeoCore Technology Co., Ltd. (1.54B), greater than Level Biotechnology Inc. (843.41M), greater than MegaPro Biomedical Co., Ltd (963.64M), greater than TCI GENE Inc. (726.20M), less than BiOptic Inc. (1.33B), greater than Neith Corporation (1.09B), greater than LAUNXP Biomedical Co., Ltd (1.02B),

Build a custom stock screener for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taiwan Advance Bio-Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taiwan Advance Bio-Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.